RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Status:
Completed
Trial end date:
2012-10-11
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine the efficacy of treatment of anemia with darbepoetin
alfa compared to placebo on the composite of time to death from any cause or first hospital
admission for worsening heart failure in patients with symptomatic left ventricular systolic
dysfunction and anemia.